C1494T mitochondrial dna mutation, hearing loss, and aminoglycosides antibiotics  by Postal, Mariana et al.
884
Brazilian Journal of otorhinolaryngology 75 (6) novemBer/DecemBer 2009
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
C1494T mitochondrial dna 
mutation, hearing loss, and 
aminoglycosides antibiotics
   Summary
Mariana Postal 1, Bruna Palodeto 2, Edi Lúcia 
Sartorato 3, Camila Andréa de Oliveira 4
 1 4th year student of biomedicine, Hermínio Ometto University - UNIARARAS.
 2 24th year student of biomedicine, Hermínio Ometto University - UNIARARAS.
 3 Associate Professor, Researcher - Center of Molecular Biology and Genetic Engineering - CBMEG-UNICAMP.
 4 PhD. Assistant Professor - Health Sciences Nucleus - NUCISA - Hermínio Ometto University - UNIARARAS.
Send correspondence to: Ana Postal, Bruna Palodetto, Edi Lúcia Sartorato, Camila Andréa De Oliveira - Nucisa - Centro Universitário Hermínio Ometto - UNIARARAS. 
Laboratório de Genética Humana/CBMEG-UNICAMP. Profa. Dra. Camila Andréa de Oliveira - Núcleo de Ciências da Saúde - NUCISA Centro Universitário Hermínio 
Ometto - UNIARARAS - Av. Maximiliano Barutto 500 Araras SP 13607-339.
Tel: + 51 (0xx19) 3543-1400 ramal 269 - E-mail: caol@uniararas.br
This study was financed by the Institutional Program of Scientific Initiation Scholarship - PIBIC/CNPq and by the Hermínio Ometto University - UNIARARAS.
Paper submitted to the BJORL-SGP (Publishing Management System – Brazilian Journal of Otorhinolaryngology) on November 6, 2008; 
and accepted on February 2, 2009. cod. 6112
In view of the complex mechanism of hearing, it is not 
difficult to understand that hearing impairment may result 
from a wide variety of genetically determined anomalies 
and various environmental factors. Specific mutations in 
the mitochondrial DNA 12S rRNA gene are responsible for 
maternally inherited non-syndromic hearing loss, and for 
increased susceptibility to the ototoxicity of aminoglycoside 
antibiotics. Aim: To asses the presence of C1494T mutation 
among individuals with normal hearing and hearing 
impairment who used aminoglycosides and those who 
had not had contact with the antibiotic. Material and 
Method: The study was composed of 20 patients with non-
syndromic sensorineural hearing loss without prior use of 
aminoglycosides and 40 premature and high-risk newborns 
who used ototoxic drugs, of whom 20 had good hearing 
and 20 had hearing loss. The samples were analyzed by 
PCR-RFLP with the restriction enzyme Hph I. Study Design: 
Experimental. Results: The mitochondrial 12S rRNA C1494T 
mutation was not detected in any of the samples analyzed. 
Conclusion: Our data suggest that the hearing loss of the 
individuals we analyzed was not related to the ototoxicity of 
mutation C1494T, showing that this mutation is not frequent 
in our population.
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INTRODUCTION
In recent years, there has been a major progress in 
our understanding of hearing mechanisms; numerous ge-
nes involved in this process have been discovered and the 
ways by which they interact has been broadly investigated. 
The hearing deficiency etiology can involve mutations in 
one single gene or a combination of mutations in different 
genes, and also environmental factors, including perinatal 
infection, brain trauma involving the cochlea or ototoxic 
drugs -aminoglycosides, or even the interaction between 
environmental and genetic factors1.
Mutations in mitochondrial DNA (mtDNA) are 
responsible for a variety of disorders which affect nume-
rous organs and tissues2. Many of the mtDNA mutations 
described in the literature are associated with syndromic 
and non-syndromic forms of hearing impairment3,4. The 
mitochondria are responsible for the availability of power 
to the cells in the form of adenosine triphosphate (ATP). 
Thus, the organs which require more energy are the ones 
that present functional alterations in cases of mitochondrial 
DNA mutations, such as nerve, muscle, endocrine, optical 
and auditory cells. As the cochlea consumes large amounts 
of energy, alterations in the mitochondrial DNA in the hair 
cells cause hearing impairment in a ratio of 0.5% to 1% of 
all the genetic hearing impairment5.
Most molecular alterations found in the mitochon-
drial DNA, which are associated with hearing impairment 
are present in genes 12S rRNA and tRNA. Especially, 
mutations affecting gene 12S rRNA are responsible for 
non-syndromic sensorineural hearing loss and a raise in 
susceptibility to the ototoxicity caused by aminoglycoside 
antibiotics6,7.
These antibiotic agents are clinically important dru-
gs, used everywhere in the world, especially in developed 
countries, in order to control bacterial infections in hospi-
talized patients. Notwithstanding, in developing countries 
these drugs are still routinely used in lesser infections8. 
Aminoglycoside antibiotic agents act by binding directly 
to the subunit 16S and 30S of bacterial ribosomal RNA 
(rRNA), causing a premature termination of the protein 
synthesis. The frequent use of these drugs causes toxicity 
involving the renal, vestibular and auditory systems. The 
renal damage is usually reversible, but the auditory and 
vestibular ototoxicity is frequently irreversible9.
Literature reports that aminoglycoside ototoxicity 
may be associated with a genetic predisposition with a 
dominant autosomal inheritance pattern, recessive, X-
linked or mitochondrial. In family cases of ototoxic hearing 
impairment caused by aminoglycoside hypersensitivity is 
frequently transmitted by maternal inheritance, suggesting 
involvement of mitochondrial genome7.
Studies held with the mitochondrial genome with 
patients with aminoglycoside ototoxicity revealed the 
identification of mitochondrial DNA mutations in gene 
12S rRNA. A1555G mutation was the first mitochondrial 
mutation described10, and since then it has been identified 
in many families, of different ethnics, segregating with non-
syndromic hearing impairment with or without exposure to 
aminoglycosides11. A little while ago, a C → T transition in 
position 1494 of gene 12S rRNA was identified in a Chinese 
family with non-syndromic sensorineural hearing impair-
ment, including individuals affected with and without 
prior exposure to aminoglycosides12 and, subsequently, 
in other two Chinese families13 and three Spanish ones14. 
The clinical heterogeneity of hearing impairment in these 
cases is directly related to the age of administration onset 
and with the duration of drug exposure. The younger the 
age of administration onset, the greater the severity of the 
hearing impairment developed by the patient15.
The A1555G mutation is structurally equivalent to 
mutation C1494T. They are both located in a highly pre-
served region of the 12S rRNA, associated with the binding 
of the aminoglycoside to the bacteria11. These mutations 
seem to alter the secondary structure of the 12S rRNA, 
in such a way as to be similar to the bacterial ribosomal 
subunit, thus leading to an increase in the susceptibility 
of aminoglycosides and consequently its ototoxic effect10.
Many biochemical studies report the pathogenic po-
tential of mutation C1494T, indicating that aminoglycosides 
modulate the hearing impairment expression potential and 
penetrance when associated with such mutation13. None-
theless, mutation C1494T was not described in any family 
of other races so far16,17. In this study, we investigated the 
presence of mitochondrial mutation C1494T among the 
patients with hearing impairment and with normal hearing 
exposed to aminoglycosides and the patients with hearing 
impairment who did not have contact with the antibiotic.
MATERIALS AND METHODS
Series
This study was characterized by a clinical and expe-
rimental research (Ethics Committee Approval # 484/2006), 
of individuals with hearing impairment without exposure 
to aminoglycoside antibiotics and in normal-hearing and 
hearing impaired newborns, premature and of high risk 
who remained in the NICU (neonatal intensive care unit) 
and had contact with the antibiotic.
The series was made up of 60 individuals, 20 with 
hearing impairment and no history of sensitization regar-
ding the use of aminoglycosides (Group B), 20 hearing 
individuals (Group C) and with audiologic diagnosis of 
non-syndromic sensorineural hearing loss (Group A, n=20) 
who used aminoglycosides. 
Gene DNA extraction
Sample analysis was carried out in DNA isolated by 
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the phenol-chloroform method18 from peripheral blood 
leucocytes after obtaining the patients’ free and informed 
consent.
12S rRNA Gene Amplification
The individuals were previously analyzed as to 
the presence of mutations to genes GJB2 and GJB6, sin-
ce mutations to these genes are responsible for a large 
proportion of cases of non-syndromic hearing loss with 
recessive autosomal inheritance19,20, and A1555G mitochon-
drial mutations to gene 12S rRNA21 and A7455G at gene 
tRNA(SerUCN)22. Among the individuals who did not have 
such mutations we investigated mutation C1494T.
From the samples of DNA extracted from the peri-
pheral blood, a 441pb fragment from the 12S rRNA gene 
sequence (GenBank: NC_001807), was amplified by PCR 
using primers C1494TF (5’-GTCGAAGGTGGATTTAG-
CAGT-3’) and C1494TR (5’-GCAGAAGGTATAGGGG-
TTAG-3’). The amplification reaction was carried out 
using 200 to 500ng of genomic DNA, 10mM of solution 
containing deoxynucleotides (dATP, dCTP, dGTP and 
dTTP), 10pmol/ml of each primer; 2,0U of Taq DNA 
polymerase; PCR 10X buffer (Tris-HCl 10mM pH 8.8) 
and 3mM of MgCl2, in a final volume of 50ml, under the 
following conditions: a denaturation cycle at 95°C for 5 
min; 30 denaturation cycles at 94°C for 30s; annealing at 
54°C for 2 min, extension at 65°C for 1mim; 7 min of final 
extension at 65°C. Amplification products were submitted 
to electrophoresis in 1% agarose gel and subsequently 
dyed in ethide bromide.
C1494T mutation identification on gene 12S rRNA
Molecular investigation of mutation C1494T on the 
12S rRNA gene was carried out by analysis of the poly-
morphism of the restriction fragments (PCR-RFLP) using 
enzyme Hph I, according to manufacturer’s specifications 
and, analyzed in 1.5% agarose gel. Allele 1494T abolishes 
the Hph I site in the sequence creating a fragment of 441pb. 
Thus, individuals with the 1494C allele have fragments of 
370pb and 71pb.
RESULTS
In an attempt to clear up the molecular aspects of 
the aminoglycosides’ ototoxic effects, we tracked down 
the C1494T mutation in 40 patients with non-syndromic 
sensorineural hearing loss. Of these, 20 patients had a 
history of using aminoglycosides. Other 20 normal hea-
ring individuals exposed to aminoglycosides, were also 
studied. After amplifying a fragment of gene 12S rRNA 
(441pb) (Figure 1) and subsequent Hph I digestion (Figure 
2) of the 60 DNA samples of patients from groups A, B 
and C, we did not identify mutation C1494T in any of the 
samples analyzed.
DISCUSSION
Functional studies show that the C1494T mutation 
causes a mild mitochondrial dysfunction and sensitivity to 
aminoglycosides, therefore indicating that the C1494T mu-
tation alone is not responsible for the hearing impairment 
phenotype. Nonetheless, the hearing loss can be increased 
by external modifying factors, such as aminoglycosides, 
and gene interactions. In cases when there is no exposure 
to aminoglycosides, the C àT transition in position 1494 of 
gene 12S rRNA has, in vivo, a weak pathogenic potential15.
Aminoglycoside ototoxicity is due to their binding to 
the receptors of inner ear hair cells. The aminoglycoside-
receptor complex formation causes changes to the cell 
membrane, to its permeability, affecting cilia function 
and, later causing the destruction of these cells23. In the 
presence of mutation C1494T the hearing cells become 
more susceptible, because the base change in a highly 
preserved region of the 12S rRNA, makes the region similar 
to the bacterial ribosomal subunit11.
Data reported from a Chinese family show that 
the interaction of mutation C1494T with other genes, in 
which those individuals with this mutation had hearing 
impairment regardless of exposure to aminoglycosides. On 
the other hand, it has also been disclosed that individuals 
with the C1494T mutation who were not exposed to the 
antibiotic did not have hearing loss12.
Figure 1. 441pb fragment from gene 12S rRNA amplified by PCR and 
analyzed in 1% agarose gel (M) - molecular weight marker (100pb).
Figure 2. Tracking C1494T mitochondrial mutation by PCR-RFLP. A 
fragment of 441pb was cleaved with the Hph I restriction enzyme. 
Normal mitochondrial DNA generates wto restriction fragments (370pb 
and 71pb) and the mutant loses the restriction site and not ’ cleaved 
by the enzyme (441pb). (M) - molecular weight marker (100pb); (1)- 
undigested PCR product. (2-12) - patients without the C1494T mutation.
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In the present study, we assessed the presence of 
C1494T mutation in hearing individuals and those with 
hearing impairment who used aminoglycosides and tho-
se who did not use the antibiotic. Nonetheless, we did 
not find positive cases for this mutation, reinforcing the 
results found in previous studies, who reported that the 
C1494T mutation is not very frequent in the world popu-
lation13,16,17,24.
CONCLUSION
Our data suggests that the hearing impairment in 
the analyzed individuals is not related to the ototoxicity 
of mutation C1494T. Nonetheless, the lack of C1494T mu-
tation in the mitochondrial genome of these individuals 
does not rule out the possibility of existing mutations in 
other genes not evaluated in this study. Thus being, later 
studies with other genes are necessary to clarify the hearing 
impairment etiology of these individuals.
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